(1,3-DIMESITYLIMIDAZOLIDIN-2-YLIDENE)(TRICYCLOHEXYLPHOSPHINE)BENZYLIDENE RUTHENIUM DICHLORIDE
UNII 6DHB6F3EXA
Substance Identification & Data
This profile provides standardized clinical and technical data for (1,3-dimesitylimidazolidin-2-ylidene)(tricyclohexylphosphine)benzylidene Ruthenium Dichloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6DHB6F3EXA.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 246047-72-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H26N2.C18H33P.C7H6.2Cl.Ru GZGCHIYGMIQZMK-UHFFFAOYSA-L Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (1,3-dimesitylimidazolidin-2-ylidene)(tricyclohexylphosphine)benzylidene Ruthenium Dichloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.